Skip to main content
Tech.euFundingExplorerBeta

Cytomos

Providing predictive analytics from suspended-cells through our unbiased cytometry technology

Cytomos has raised €12M across 3 funding rounds from 4 investors, most recently a round in Nov 2024. Based in Edinburgh, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€12M
€12,473,701
Funding rounds
3
Investors
4
distinct backers
Active since
2022-06
latest 2024-11

Funding by year

EUR raised per year
Cytomos — funding by year — interactive chart.
Data table
Cytomos — funding by year
2022€1.9M
2023€4.6M
2024€6.0M

Signals

High confidence
Raise-next likelihood32
base rate 30% for Other
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData